UK-based Intelligent Fingerprinting has announced the availability of its new fingerprint-based drug screening system to drug rehabilitation service providers. The company’s revolutionary technology detects drug use by analysing fingerprint sweat, screening for multiple drugs of abuse in under 10 minutes. Its dignified, non-invasive approach makes it an ideal choice to support drug recovery programmes that currently rely on oral-fluid or urine-based drug tests to track clients’ progress.
The new fingerprint-based drug test is portable, offering a convenient drug screening approach for use by drug rehabilitation services in both clinics and community-based centres. The system makes it simple to set up screening sessions, collect samples, administer tests and get results quickly on location. Fingerprint drug testing is also particularly easy to use and non-invasive, sidestepping potential hygiene concerns associated with traditional screening methods that involve the collection and disposal of body fluid samples such as saliva or urine.
“Drug rehabilitation providers need to maintain an open relationship with clients that’s based on trust, so it’s critical that drug testing is quick, easy and – most importantly – dignified,” commented Dr Jerry Walker, Chief Executive Officer, Intelligent Fingerprinting. “Our new fingerprint drug test can help drug rehabilitation programmes to deliver drug screening directly in communities in a positive way, while also helping measure each client’s progress towards recovery.”
The Intelligent Fingerprinting Drug Screening System consists of a sample collection cartridge and the portable Reader 1000, and works by analysing the tiny traces of sweat contained in a fingerprint to detect signs of drug use. Collecting a fingerprint sweat sample onto an Intelligent Fingerprinting cartridge takes just five seconds, and the Reader 1000 provides a positive or negative result for each drug in the test within just 10 minutes.
Supporting drug rehabilitation programmes
Rehabilitation programmes rely on regular drug screening to measure treatment progress and identify the need for intervention if a relapse occurs. Current drug screening methods are time-consuming, undignified and involve bio-hazardous samples such as urine and saliva which may require specially prepared sample collection areas, gender-specific staff for observed collection of urine samples, bulky storage and clinical waste disposal services.
Christopher Strivens is Deputy Service Manager at Norfolk Recovery Partnership, which provides advice and treatment for adults with drug and alcohol problems across Norfolk and is run by a partnership of Norfolk and Suffolk NHS Foundation Trust, The Matthew Project and The Rehabilitation of Addicted Prisoners Trust. He said: “With Intelligent Fingerprinting, there’s now a drug screening approach that is non-invasive and undertaken with ease. The Intelligent Fingerprinting drug screening system’s portability and non-invasive nature means that our screening sessions don’t need to be carried out in a clinical setting, while there is no clinical waste or risk to staff from the collected sample. That makes it much easier to set up sessions, collect samples, administer tests and get results in under 10 minutes. Our service users have found the devices very acceptable and easy to use, and this helps to establish positive relationships with them.”
To learn more about how non-invasive drug screening works, and how it has the potential to revolutionise drug screening in drug rehabilitation organisations, view the Intelligent Fingerprinting introductory video:
For media information contact Cheryl Billson at Comma
Email: firstname.lastname@example.org Tel: +44 (0)7791 720460
Notes to Editors:
About Intelligent Fingerprinting
Intelligent Fingerprinting’s unique fingerprint-based portable Drug Screening System is set to revolutionise the way drug screening is carried out across a range of sectors. The distinctive Intelligent Fingerprinting technology, which works by analysing the sweat from a fingerprint sample, enables non-invasive, cost-effective screening for multiple drug groups in less than 10 minutes (currently amphetamines, cannabis, cocaine and opiates).
Intelligent Fingerprinting has attracted worldwide interest in its technology from a wide range of drug-screening markets including the criminal justice arena, drug rehabilitation centres, prisons and occupational health services. The technique has potential for many other uses including healthcare diagnostics and homeland security applications.The company’s
The company’s groundbreaking technology detects drug use by analysing chemicals, known as metabolites, contained in the minute traces of sweat found in a fingerprint. (Metabolites are chemicals produced by the body as a result of normal metabolic processes.) The Intelligent Fingerprinting Drug Screening System looks for the presence of specific drugs or drug metabolites in the test subject’s fingerprint sweat sample and, if detected, identifies which drugs have been consumed.
Since 2012 Intelligent Fingerprinting has raised £11.23m in funding from a consortium of private UK and US-based investors, as well as government funding for pilot studies within the UK’s National Health Service and coroners’ services.
Founded in 2007, Intelligent Fingerprinting is a spin-out company from the University of East Anglia (UEA). The company is based in Cambridge, England and currently employs 30 people.
Follow us on Twitter @iFingerprinting